P-096A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress. (20th June 2018) - Bang, Y; Van Cutsem, E; Fuchs, C; Ohtsu, A; Tabernero, J; Ilson, D; Hyung, W; Strong, V; Goetze, T; Yoshikawa, T; Tang, L; Hwang, P; et al.